Oric Pharmaceuticals (ORIC) News Today $9.93 +0.10 (+1.02%) Closing price 04:00 PM EasternExtended Trading$9.83 -0.10 (-1.00%) As of 04:41 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock ORIC Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Oric Pharmaceuticals (NASDAQ:ORIC) Posts Earnings Results, Misses Expectations By $0.01 EPS4 hours ago | marketbeat.comOric Pharmaceuticals Focuses on Lead Clinical ProgramsAugust 12 at 10:58 PM | msn.comOric Pharmaceuticals reports Q2 EPS (47c), consensus (44c)August 12 at 10:58 PM | msn.comOric Pharmaceuticals Logs Wider 2Q Loss, Plans to Cut 20% of WorkforceAugust 12 at 5:57 PM | marketwatch.comORIC® Pharmaceuticals Reports Second Quarter 2025 Financial Results and Operational UpdatesAugust 12 at 4:05 PM | globenewswire.comVivo Capital LLC Purchases 802,632 Shares of Oric Pharmaceuticals, Inc. (NASDAQ:ORIC)August 9, 2025 | marketbeat.comOric Pharmaceuticals (ORIC) Projected to Post Quarterly Earnings on MondayAugust 9, 2025 | americanbankingnews.comORIC Pharmaceuticals: What It Takes To Be Best In ClassAugust 7, 2025 | seekingalpha.comOric Pharmaceuticals (ORIC) to Release Earnings on MondayAugust 5, 2025 | marketbeat.comBrokerages Set Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) Target Price at $18.57August 5, 2025 | americanbankingnews.comORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)August 1, 2025 | globenewswire.comVictory Capital Management Inc. Purchases 52,760 Shares of Oric Pharmaceuticals, Inc. (NASDAQ:ORIC)August 1, 2025 | marketbeat.comOric Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives Consensus Rating of "Buy" from BrokeragesJuly 31, 2025 | marketbeat.comOric Pharmaceuticals (NASDAQ:ORIC) Shares Down 8.2% - Here's What HappenedJuly 30, 2025 | marketbeat.comNew York State Common Retirement Fund Has $215,000 Stock Position in Oric Pharmaceuticals, Inc. (NASDAQ:ORIC)July 27, 2025 | marketbeat.comOric Pharmaceuticals, Inc. (ORIC) Now Trades Above Golden Cross: Time to Buy?July 15, 2025 | finance.yahoo.comOric Pharmaceuticals, Inc. (ORIC) is a Great Momentum Stock ... - NasdaqJuly 13, 2025 | nasdaq.comOric Pharmaceuticals (NASDAQ:ORIC) Shares Down 4.9% - Here's What HappenedJuly 11, 2025 | marketbeat.comLadenburg Thalmann Initiates Coverage of ORIC Pharmaceuticals (ORIC) with Buy RecommendationJuly 9, 2025 | msn.comOric Pharmaceuticals (NASDAQ:ORIC) Now Covered by LADENBURG THALM/SH SHJuly 8, 2025 | marketbeat.comOric Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives Consensus Recommendation of "Buy" from AnalystsJuly 6, 2025 | marketbeat.comORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635 (c) (4) - MorningstarJuly 5, 2025 | morningstar.comMORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)July 3, 2025 | globenewswire.comMetastatic Prostate Cancer Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsightJuly 3, 2025 | theglobeandmail.comOric Pharmaceuticals (NASDAQ:ORIC) Trading 10% Higher - Time to Buy?July 2, 2025 | marketbeat.comOric Pharmaceuticals Inc. Advanced Charts | ORIC | Barron'sJune 28, 2025 | barrons.comOric Pharmaceuticals Shows Market Leadership With Jump To 93 RS RatingJune 25, 2025 | msn.comOric Pharmaceuticals, Inc. (NASDAQ:ORIC) CFO Sells $10,340.00 in StockJune 25, 2025 | insidertrades.comOric Pharmaceuticals, Inc. (NASDAQ:ORIC) CFO Dominic Piscitelli Sells 1,034 SharesJune 24, 2025 | marketbeat.comOric Pharmaceuticals, Inc. (NASDAQ:ORIC) CFO Sells $340,893.00 in StockJune 24, 2025 | marketbeat.comOric Pharmaceuticals (NASDAQ:ORIC) Shares Gap Up Following Insider Buying ActivityJune 24, 2025 | marketbeat.comAngie You Purchases 1,403 Shares of Oric Pharmaceuticals, Inc. (NASDAQ:ORIC) StockJune 24, 2025 | insidertrades.comOric Pharmaceuticals, Inc. (NASDAQ:ORIC) Director Angie You Acquires 26,597 SharesJune 23, 2025 | marketbeat.comOric Pharmaceuticals, Inc. (NASDAQ:ORIC) Director Angie You Acquires 1,403 SharesJune 23, 2025 | marketbeat.comOric Pharmaceuticals (NASDAQ:ORIC) Stock Price Up 6.2% - Here's What HappenedJune 23, 2025 | marketbeat.comOric Pharmaceuticals (NASDAQ:ORIC) Receives Outperform Rating from WedbushJune 23, 2025 | marketbeat.comORIC Pharmaceuticals (NASDAQ:ORIC) Shares Down 3.4% - Should You Sell?June 16, 2025 | marketbeat.comORIC Pharmaceuticals (NASDAQ:ORIC) Shares Gap Down on Insider SellingJune 12, 2025 | marketbeat.comMillennium Management LLC Trims Stock Position in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC)June 12, 2025 | marketbeat.comORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) CFO Dominic Piscitelli Sells 2,976 SharesJune 11, 2025 | marketbeat.comOric Pharmaceuticals files to sell 19.23M shares of common stock by selling shareholdersJune 11, 2025 | msn.comCantor Fitzgerald Weighs in on ORIC FY2026 EarningsJune 11, 2025 | marketbeat.comORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Receives Average Rating of "Buy" from AnalystsJune 11, 2025 | marketbeat.comInsider Selling: ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) CFO Sells 2,600 Shares of StockJune 10, 2025 | insidertrades.comORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) CFO Sells $26,026.00 in StockJune 9, 2025 | marketbeat.comORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Shares Acquired by Bank of America Corp DEJune 8, 2025 | marketbeat.comORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)June 6, 2025 | globenewswire.comORIC Pharmaceuticals (NASDAQ:ORIC) Shares Gap Up - Still a Buy?June 6, 2025 | marketbeat.comTwo Sigma Investments LP Decreases Position in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC)June 6, 2025 | marketbeat.comORIC Pharmaceuticals (NASDAQ:ORIC) Trading 7.6% Higher - Still a Buy?June 4, 2025 | marketbeat.com Get Oric Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ORIC and its competitors with MarketBeat's FREE daily newsletter. Email Address ORIC Media Mentions By Week ORIC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ORIC News Sentiment▼-0.010.61▲Average Medical News Sentiment ORIC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ORIC Articles This Week▼134▲ORIC Articles Average Week Get Oric Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ORIC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Apellis Pharmaceuticals News Today Scholar Rock News Today Mirum Pharmaceuticals News Today MorphoSys News Today NewAmsterdam Pharma News Today AMNEAL PHARMACEUTICALS News Today Ultragenyx Pharmaceutical News Today Kymera Therapeutics News Today Immunovant News Today HUTCHMED News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ORIC) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oric Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oric Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.